Hemodialysis Service, Department of Surgery, Università Cattolica del Sacro Cuore di Roma, Largo A. Gemelli 8, 00168, Rome, Italy.
Int Urol Nephrol. 2013 Aug;45(4):1091-6. doi: 10.1007/s11255-012-0212-2. Epub 2012 Jun 10.
Appetite in patients on chronic hemodialysis (HD) may be constantly very good/good or fair/poor or may fluctuate up and down over time. When constantly fair/poor, appetite has been shown to be associated with older age, more comorbidities, and more hospitalizations; however, it is unknown if it predicts survival. The aim of the present study was to assess appetite monthly for 6 months in patients on chronic HD and to determine if the course of appetite over time predicts mortality.
Ninety-two HD patients were evaluated at baseline for appetite, nutritional and inflammatory markers, comorbid conditions, and Charlson's comorbidity index. Appetite assessment was repeated monthly for 6 consecutive months. Survival in relation with the course of appetite over time was determined.
Appetite was constantly very good/good in 45 patients (Group 1), fair/poor/very poor in 30 (Group 2), and fluctuated in 17 (Group 3). Twenty-seven (29.3 %) patients died after a mean period of 28 ± 13 months. Overall, the mean survival time was 42.1 ± 1.2 months. For Groups 1, 2, and 3, the mean survival time was 46.1 ± 0.92, 37.9 ± 2.5, and 39.1 ± 3.7 months, respectively (p < 0.0001). After multivariate logistic regression analysis, the course of appetite over time was not found to be an independent risk factor for mortality.
The course of appetite over time does not seem to predict mortality in patients on chronic hemodialysis. Considering that the study included a relatively small number of patients, larger similar studies are desirable.
慢性血液透析(HD)患者的食欲可能一直很好/好,或一般/差,或随时间上下波动。当持续一般/差时,食欲已被证明与年龄较大、合并症较多和住院次数较多有关;然而,尚不清楚它是否预测生存率。本研究的目的是评估慢性 HD 患者 6 个月的每月食欲,并确定随时间推移食欲的变化是否预测死亡率。
92 例 HD 患者在基线时评估食欲、营养和炎症标志物、合并症和 Charlson 合并症指数。每月重复评估食欲,连续 6 个月。确定与随时间推移的食欲变化相关的生存情况。
45 例患者(第 1 组)的食欲一直很好/好,30 例(第 2 组)的食欲一般/差/很差,17 例(第 3 组)的食欲波动。27 例(29.3%)患者在平均 28±13 个月后死亡。总体而言,平均生存时间为 42.1±1.2 个月。对于第 1、2 和 3 组,平均生存时间分别为 46.1±0.92、37.9±2.5 和 39.1±3.7 个月(p<0.0001)。经过多变量逻辑回归分析,随时间推移的食欲变化不是死亡率的独立危险因素。
随时间推移的食欲变化似乎不能预测慢性血液透析患者的死亡率。考虑到该研究纳入的患者数量相对较少,需要进行更大规模的类似研究。